Harbor is a licensed detox provider in Bowling Green, OH, listed in the SAMHSA treatment directory. Its team manages alcohol withdrawal, including the delirium tremens that can peak in the first two to four days. For opioid dependence it provides medically supervised detox, and it can pair that with medication to ease withdrawal. Buprenorphine (Suboxone) is offered to reduce opioid withdrawal and lower relapse and overdose risk. Detox is available on an outpatient basis, so clients can withdraw while living at home with scheduled visits. The facility reports accepting Medicaid. Private health insurance is accepted. It serves children/adolescents, young adults, seniors.
Availability and current services change often. Call (888) 984-9911
and we will help you confirm openings, insurance, and next steps.
Detox services
Alcohol DetoxificationOpioids detoxificationMedication routinely used during detoxification
Level of care
OutpatientOutpatient detoxificationIntensive outpatient treatmentOutpatient methadone/buprenorphine or naltrexone treatmentRegular outpatient treatment
Medications
Buprenorphine used in TreatmentNaltrexone used in Treatment
Payment accepted
Federal, or any government funding for substance use treatment programsMedicareMedicaidFederal military insurance (e.g., TRICARE)Private health insuranceCash or self-paymentState-financed health insurance plan other than MedicaidSAMHSA funding/block grants
Ages served
Children/AdolescentsYoung AdultsSeniors
Accreditation
State substance use treatment agencyState mental health departmentCommission on Accreditation of Rehabilitation Facilities (CARF)
Free & confidential, 24/7
Not sure which program fits? Talk it through with someone who can help.
Alcohol DetoxificationBenzodiazepines DetoxificationCocaine DetoxificationFederal, or any government funding for substance use treatment programsMedicare
6855 Spring Valley Drive, Suite 110, Holland, OH 43528
Alcohol DetoxificationOpioids detoxificationMedication routinely used during detoxificationFederal, or any government funding for substance use treatment programsMedicare